Wellinks Announces Initiation of IRB Approved Study of Digital Health Solution for COPD
NEW HAVEN, Conn., Jan. 14, 2021 /PRNewswire/ --Wellinks, a leader in innovative respiratory technologies today announced the initiation of an IRB approved research pilot study for patients previously diagnosed with COPD.
- NEW HAVEN, Conn., Jan. 14, 2021 /PRNewswire/ --Wellinks, a leader in innovative respiratory technologies today announced the initiation of an IRB approved research pilot study for patients previously diagnosed with COPD.
- The study aims to demonstrate the feasibility of collecting and tracking information essential to the management of patients with COPD including adherence to medication regimen, lung health, and symptoms onset among others.
- "Getting into the field with our first digital health offering and welcoming patients on the platform is an exciting milestone for us," says Wellinks President Geoff Matous.
- Wellinks research shows that despite greater than 80% of COPD sufferers would be open to digital health tools, only 10% use them today.